Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Jiwon Oh MD, PhD, FRCPC

Jiwon Oh MD, PhD, FRCPC

Medical Director, Barlo Multiple Sclerosis Program, Associate Professor, and Staff Neurologist, Division of Neurology, St. Michael’s Hospital, University of Toronto; Scientist, Keenan Research Centre of the Li Ka Shing Knowledge Institute, Toronto, Ontario, Canada

Jiwon Oh is a staff neurologist, scientist, and Medical Director of the Barlo Multiple Sclerosis (MS) Program at St. Michael’s Hospital, University of Toronto and specializes in the care of people living with MS.

Dr. Oh’s research focuses on developing advanced MRI techniques in for use in clinical settings, and the development of large datasets. She leads the MRI research program at St. Michael’s Hospital, and is the principal investigator on numerous local and multi-center collaborative studies, including the Canadian Prospective Cohort Study to Understand Progression in MS (CanProCo), which is a national prospective cohort study designed to better understand progression in MS.

Dr. Oh is one of the founding members of the North American Imaging in MS Cooperative (NAIMS) representing a multi-national collaborative MRI research endeavor in MS with over 40 sites in North America. She is deeply committed to caring for people with MS, educating future generations of clinicians and scientists, and contributing to scientific developments that will drive the field forward.


Dr. Jiwon Oh has received grant funding from Biogen-Idec, Roche, and EMD-Serono and has received personal compensation for consulting or speaking from Biogen-Idec, EMD-Serono, Eli-Lilly, Horizon Therapeutics, Novartis, Roche, and Sanofi-Genzyme.

Recent Contributions to PracticeUpdate:

  1. Three Distinct Endophenotypes Identified in Patients With MS